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ABSTRACT 
Kadel, Saurav. M.S.R.C.E., Department of Mechanical and Materials Engineering, 
Wright State University, 2020. Computational Assessment of Aortic Valve Function and 
Mechanics under Hypertension 
Calcific aortic valve disease (CAVD), the most common valvular heart disorder, is 
associated with complications such as stroke, heart attack, aortic aneurysm, left ventricular 
hypertrophy, and ultimately death. While hypertension has been identified as a major risk 
factor for CAVD, the mechanisms by which it may promote calcification are still unknown. 
Given the sensitivity of valvular tissue to mechanical stress alterations, the hemodynamic 
abnormalities linked to hypertension may play a role in the development of CAVD. 
Further, the effects of hypertension on the left ventricular functionality and coronary flow 
resistance remain largely uninvestigated. Hence, the objectives of this thesis were 1.) to 
quantify computationally AV hemodynamics and regional leaflet mechanical stresses 
under normotensive, prehypertensive and stage-1 hypertensive conditions using Fluid-
Structure interaction modeling, and 2.) characterize the effect of hypertensive conditions 
on ventricular workload and coronary flow resistance. This study will provide insights on 
the mechano-etiology of CAVD in hypertensive patients as well as the ventricular 
functionality and coronary flow under hypertension. 
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The human circulatory system consists of the heart, the heart valves which ensure 
unidirectional blood flow, the system of blood vessels, and the circulating blood, which act 
in harmony to control blood flow to the various tissues and organs. 
1.1 Heart Anatomy and Physiology 
 
The heart is the primary organ of the cardiovascular system and is crucial for blood 
circulation. It can be separated sagitally into left and right sides by a large muscular wall 
known as the interventricular septum (Figure 1 [1]). Each side can further be segregated 
into two superior and inferior chambers known as the atria and ventricles, respectively. The 
left side of the heart is responsible for systemic circulation whereas the right side is 
responsible for the pulmonary circulation. Briefly, pulmonary circulation is defined as the 
route traveled by blood from the various tissues and organs to the right side of the heart, 
where it is pumped to the lungs for oxygenation and gas exchange. The systemic circulation 
encompasses the route of the freshly oxygenated blood from the lungs to the left side of 
the heart, where it is subsequently pumped to the rest of the body. 
Unidirectional blood flow in the heart is maintained throughout the cardiac cycle 
with the help of four distinct heart valves: the atrioventricular valves (left: mitral valve,
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right: tricuspid valve) located at the junction between each chamber, and the semilunar 
valves (left: aortic valve, AV, right: pulmonary valve) located at the junction between each 
ventricle and corresponding artery.  
The cardiac cycle is divided into two phases: diastole and systole. During the diastolic 
phase, blood from different parts of the body returns to the heart and flows into the right 
atrium increasing the pressure in the right atrium (Figure 2a [2]). The tricuspid valve opens 
when this pressure exceeds the right ventricular pressure, allowing blood to flow passively 
into the right ventricle. Simultaneously, oxygenated blood returning from the lungs fills 
the left atrium, which then flows into the left ventricle through the mitral valve due to an 
increase in left atrial pressure. During systole (Figure 2b [2]), the atrial contraction forces 
the remaining blood from the two atria to flow into their ventricles. This is followed by a 
phase of isovolumetric contraction in which the ventricles contract, but the ventricular 
pressure does not exceed the aortic pressure forcing the semilunar valves and the 
atrioventricular valves to remain closed. When the ventricular pressure exceeds the aortic 
Figure 1: Heart anatomy [1] 
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pressure, the semilunar valves open and blood flows into the aorta and then to the rest of 
the body. The heart muscle relaxes by the end of systole and the diastolic phase begins 
again.  
1.2 Left Ventricle Anatomy and Physiology 
Located at the bottom left of the heart, the left ventricle (LV) is the largest heart 
chamber. It contracts and expands to eject blood into the aorta. The LV consists of thick 
muscular walls, which aids in the high-pressure systolic ejection. 
 In the systemic circulation, the LV contraction increases the pressure within the 
ventricle from 0 mmHg to a peak-systolic pressure of about 120 mmHg, overcoming the 
arterial resistance. This allows for oxygenated blood to flow into the aorta and then to the 
rest of the body. LV function is measured by cardiac output (CO), which quantifies the 
amount of blood pumped per minute and is calculated as the product of the stroke volume 
Figure 2: Schematic showing heart valve function during systole (a) and diastole (b) [2] 
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and the heart rate. An adult human body typically has a CO of 5.0 L/min, stroke volume of 
70 ml, and a  heart rate of 70 beats per minute for a cardiac cycle of 0.86 seconds [3]. 
1.3 Aortic Valve Anatomy and Physiology 
The aortic valve (AV), situated between the LV and the aorta, allows for 
unidirectional blood flow from the heart throughout the systemic circulation. The valvular 
opening and closing mechanism are facilitated by the transvalvular pressure gradient 
(TPG), which is the pressure difference between the LV and the aorta. During diastole, the 
aortic and left ventricular pressure (80 and 0 mmHg, respectively) result in a negative TPG, 
which closes the valve. The valve opens due to the positive TPG resulting from the 
increased LV pressure (up to 120 mmHg) and aortic pressure (80 to 120 mmHg) during 
systolic contraction. 
 The AV features three semilunar leaflets housed in a region known as the aortic 
root at the base of the aorta (Figure 3a [4]). Three hemispherical cavities, known as the 
sinus of Valsalva, asymmetrically protrude from the root. Two of these sinuses house the 
Figure 3: Aortic valve anatomy (a) [4] and unfolded valve showing the leaflets and 
the sinuses (b) [5]
5 
coronary ostia, which are the openings that connect the sinuses to their respective coronary 
artery (left coronary artery, right coronary artery) (Figure 3b [5]). The leaflets and the 
sinuses are named based on their proximity to the ostia and are known as the left-coronary, 
right-coronary and non-coronary leaflet/sinus.  
AV leaflets consist of different regions (Figure 4a [6]). The topmost margin of the 
leaflet is called the free edge. The region where the free edge and the aorta meet are called 
the commissures. The coaptation zone is the upper region of the leaflet just below the free 
edge, which provides a contact region between the three leaflets during valve closure. The 
bottom portion is called the belly, which consists of the attachment edge that connects the 
leaflet to the sinus. The leaflet thickness varies spatially across those regions and is also 
dependent on the leaflet. Histologically, AV leaflets feature a tri-layered structure, which 
consists of the fibrosa, the ventricularis, and the spongiosa. The fibrosa faces the aorta side 
and consists of circumferentially oriented collagen fibers, valve interstitial cells (VICs), 
valve endothelial cells (VECs), and elastin fibers (Figure 4b [7]). The collagen fibers 
provide strength to the leaflets whereas the elastin fibers contribute to the flexibility and 
reduce radial strain. VICs maintain the valvular structural integrity. VECs are the outer 
lining of the AV leaflets that protect from cell infiltration and lipid accumulation. VECs 
play an important role in valvular homeostasis as they respond to strain and wall shear 
stress (WSS) by changing their morphology, functions, and gene and protein expression 
[8], [9]. The ventricularis faces the LV and is predominantly comprised of VICs, VECs, 
and radially oriented elastin fibers, which helps the valve endure bending motion over the 
cardiac cycle. The spongiosa, located between the fibrosa and the ventricularis, mainly 
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consists of glycosaminoglycans (GAGs), which provide lubrication and cushioning effect 
to dampen the compressive forces on the leaflets. 
1.4 Coronary Flow 
  Originating from the coronary ostias, the two coronary arteries are responsible for 
supplying oxygenated blood to the heart muscles. The left coronary artery (LCA) and the 
Figure 4: Sectional view of a leaflet showing different regions (a) [6] and 
cellular architecture of the aortic valve (b): A) VECs, B) VICs, C) collagen, D) 
GAGs, E) Elastin [7] 
Figure 5: Schematic of coronary arteries [10] 
7 
right coronary artery (RCA) supplies blood to the left ventricular wall and right ventricular 
wall, respectively, as well as the interventricular septum (Figure 5 [10]).  
Coronary perfusion pressure (CPP), which is the difference between the diastolic 
aortic pressure and end-diastolic left ventricular pressure [11] and coronary resistance drive 
the coronary flow [12], [13]. During systole, the myocardial contraction causes a collapse 
of the coronary arteries, which leads to a reduction of coronary blood flow. During diastole, 
the heart muscle relaxes, which causes maximum coronary blood flow. Arteries are 
generally able to maintain constant blood flow to the organs across a wide range of driving 
pressure through a process known as autoregulation [14]-[15]. Changes in the arterial 
resistance, which are achieved by changes in arterial diameter (remodeling) and blood 
viscosity, are considered the primary mechanism behind autoregulation. As compared to 
other components of the vasculature, the coronary arteries exhibit an advanced 
autoregulatory capacity [16], which results in the maintenance of a relatively constant 
blood flow despite changes in CPP. Coronary flow remains unaffected for CPP ranging 
from 60 to 130 mmHg [17] and mean arterial pressure ranging from 60 to 140 mmHg [18]. 
Coronary flow becomes pressure-dependent outside this range. 
Coronary flow plays a crucial role in AV hemodynamics. The presence of sinus 
vortices and their role in aiding leaflet closure have been well documented in many studies 
[19], [20]. To better understand this, an experimental study was carried out on the AV to 
demonstrate the impact of coronary flow on sinus hemodynamics and AV leaflet 
mechanics [21]. The study not only showed that the coronary flow generated complex 
vortex dynamics and increased velocity close to the base of leaflet, but also resulted in a 
larger valve opening area and increased WSS in the leaflet base, which was not observed 
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in the non-coronary sinus. Another computational study showed that the presence of 
coronary circulation led to the suppression of vortices in the coronary sinuses, which 
subsequently generated alterations in leaflet WSS environment [22]. 
1.5 Calcific Aortic Valve Disease  
Calcific aortic valve disease (CAVD), or the formation of calcific nodules on the 
AV leaflets, is the most common AV disease and the third most common heart disease. 
CAVD is a slow progressive disorder that is characterized with mild valvular leaflet 
thickening at the beginning, known as aortic sclerosis. Aortic sclerosis affects about 25% 
of the geriatric population [23]. As the disease progresses, the thickened leaflets undergo 
calcification on the fibrosa, leading to aortic stenosis (AS), overtime (Figure 6 [24]). AS 
causes substantial reduction in the orifice area and valve functionality. It is prevalent in 
0.4% of the general population and 1.7% of the geriatric population [25]. AS is associated 
with high mortality rates: up to 50% in the first two years after symptoms appear [26], [27]. 
The symptoms of CAVD are fatigue, shortness of breath, fainting, chest pain and heart 
murmur. Left untreated, the disease eventually leads to the narrowing of the valve orifice, 
obstruction in blood flow, coronary heart disease, and death [28]. Traditional risk factors 
Figure 6: CAVD progression from healthy to sclerosis and stenosis [24] 
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of CAVD are age, cigarette smoking, male sex, hypertension, increased lipoprotein and 
diabetes mellitus [7].  
CAVD pathogenesis can be divided into three stages: inflammation, fibrosis and 
calcification [29]–[32]. The inflammatory stage is characterized by cellular infiltration, 
lipids accumulation and expression of pro-inflammatory cytokines such as transforming 
growth factor beta-1 (TGF-ß1) and bone morphogenic proteins (BMPs). In the fibrotic 
stage, the fibroblast-like phenotype differentiates into myofibroblast- or osteoblast-like 
phenotype. Also, the loss of balance between matrix metalloproteinases (MMPs) and the 
tissue inhibitors of matrix metalloproteinases (TIMPs), causes the disorganized 
extracellular matrix (ECM) fibers to accumulate and lead to leaflet thickening. Lastly, in 
the calcification stage, cytokines released by the osteoblasts-like VICs activate pro-calcific 
pathways leading to calcific lesion formation on the fibrosa. 
The severity of CAVD is measured by the effective orifice area (EOA), the orifice 
jet velocity and the mean TPG (Table 1) [33]. The EOA is the minimum cross-sectional 
area of the jet downstream of the valve orifice. In a healthy AV under normal conditions, 
the EOA has been reported to be in the range of 3-5 cm2 [34].  
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Table 1: Classification of CAVD severity 
AV jet velocity (m/s)  Mean TPG (mmHg) EOA (cm2) 
Aortic sclerosis < 2.5 < 10 3-4
Mild AS 2.5 – 3 10-20 1.5-3.0 
Moderate AS 3-4 20-40 1.0-1.5 
Severe AS > 4 > 40 < 1.0 
1.6 Treatment for CAVD 
The most common treatment of CAVD involves the replacement of the AV. 
Prosthetic valves such as bileaflet mechanical valves and bioprosthetic valves have been 
used for AV replacement. Bileaflet mechanical valves consist of two semilunar disks 
hinged to a fixed valvular ring, which makes them very durable (Figure 7a) [35]. However, 
patients with mechanical valves are required to take lifelong anticoagulation medication to 
avoid the formation of blood clots due to the thrombogenic leaflet material used [36]. 
Bioprosthetic valves, on the other hand, consist of porcine or bovine AV leaflets mounted 
on a polymeric or metallic stent (Figure 7b). These bioprosthetic valves do not require 
anticoagulation medication, but interventions are required every 10-15 years due to their 
limited durability and lifespan [37], [35]. Although AV replacements with prosthetic valves 
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are effective, they require open heart surgery, which is not ideal for elderly and inoperable 
patients. To address that need, a noninvasive transcatheter aortic valve replacement 
(TAVR) was introduced in 2002. TAVR utilizes a valve made of animal tissue folded in 
an expandable stent, which is carried by a catheter through the femoral artery and guided 
to the AV. The new implant is stationed, and the stent is expanded inside the diseased valve 
(Figure 7c). TAVR has a high success rate and has been used in more than 80,000 cases 
[38], but some patients have been diagnosed with complications like stroke, coronary 
obstruction, valvular leakage, hypotension, renal injury and necessity of pacemaker after 
treatment [39], [40], [41]. Although TAVR has a lower mortality rate than standard valve 
prostheses, over  25% of post-TAVR patients either do not recover their normal way of life 
or die [42].  
1.7 Hypertension 
Hypertension is a common risk factor of CAVD with over 60% of hypertensive 
patients developing CAVD [43]. Hypertension affects 26% of the global population [44] 
and over 45% of the adult population in the United States [43]. At rest, for most adults, 
normal arterial blood pressure (BP) varies between 120 mmHg during systole and 80 
Figure 7: Bileaflet mechanical valve (a), stented porcine bioprosthetic valve (b), 
bioprosthetic expanded over a balloon (TAVR) (c) [35]
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mmHg during diastole. Hypertension, or high blood pressure, is defined as the persistent 
increase in the systolic/diastolic BP from normal BP. Hypertension is classified into two 
stages (Table 2) with blood pressure greater or equal to 130/80 mmHg (systolic/diastolic) 
considered hypertensive [45]. 
Table 2: Stages of blood pressure 





Normal ≤ 120 ≤ 80 
Elevated or prehypertension 120-129 ≤ 80 
Hypertension stage-1 130-139 80-89
Hypertension stage-2 140 or higher 90 or higher 
Primary hypertension, which affects 90-95% of hypertensive patients, has no 
identifiable cause. Secondary hypertension, which affects the remaining 5-10% of 
hypertensive patients, is linked to renal disease, endocrine disorders, or other identifiable 
causes [46]. In both hypertension types, the actual increase in blood pressure is associated 
with either an increase in systemic vascular resistance (SVR) or an increase in CO [47]. 
Chronic hypertension is mostly associated with an increase in SVR rather than CO. The 
increased SVR is caused by an increase in wall thickness of the blood vessels and by a 
decrease in vessel diameter. Increased sodium retention in the blood due to renal disorders, 
higher sympathetic activity and increase in angiotensin II levels have been shown to 
increase the CO and SVR [48], [49]. The common risk factors of hypertension are age, 
race, obesity, smoking, alcohol, stress and chronic conditions such as kidney disease, 
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diabetes and sleep apnea. Hypertension leads to a host of diseases like heart attack, stroke, 
aneurysm, chronic kidney disease, vision loss and dementia in the long run [50]. Most 
people diagnosed with hypertension are treated with antihypertensive medications in 
addition to lifestyle modification. 
1.8 Left Ventricular Hypertrophy 
Left ventricular hypertrophy (LVH) is the increase in the muscular mass of the LV 
due to the thickening of the wall muscles. LV needs to pump blood regularly irrespective 
of different heart conditions like hypertension and AS. LVH is prevalent in 17-67% of 
patients with CAVD [51] and 36-41% of hypertensive patients [52]. The narrowing of the 
valve opening and obstruction of blood flow due to AS or the elevated aortic pressure under 
hypertension [53], [54], forces the LV to pump harder. To compensate for the increased 
workload, the muscular LV wall thickens and, in the process, alters the LV geometry. This 
mechanism helps in maintaining a physiologic CO. Left untreated, the thickened muscles 
ultimately lose their elasticity and may fail to maintain the CO leading to heart attack and 
stroke. LVH caused by AS might require AV repair or replacement. In hypertensive case, 
medication is the preferred treatment. 
1.9 Etiologies of CAVD 
Genetic factors have been the most common etiology of CAVD. Genetic mutations 
of the transcriptional factor NOTCH1 [55]–[57], which controls the process of osteogenic 
differentiation, has been extensively studied under the genetic theory behind CAVD. Gene 
coding for the vitamin D receptor [58] and lipoproteins synthesis [59] have also been 
identified in patients with CAVD.  
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Although CAVD has been historically linked to a genetic origin, an alternate 
hemodynamic theory has emerged. The hemodynamic theory (Figure 8) proposes that risk 
factors such as age, hypertension and bicuspid aortic valve (BAV) could produce 
hemodynamic stress abnormalities on the AV leaflets. VECs can sense the altered stresses 
and then transduce them into various biological responses that might lead eventually to 
leaflet calcification. Calcification can then increase the degree of hemodynamic 
abnormality on the leaflets, which may contribute to disease progression. 
1.9.1. Support for the Hemodynamic Theory 
 WSS is the frictional viscous stress acting on the wall due to the spatial gradient of 
blood flow velocity. Physiologic WSS levels have been shown to play an important role in 
the maintenance of valvular homeostasis [60], [61], while WSS alterations have been 
shown to trigger a pathological response in the AV leaflets [62]. An ex vivo study in 
Figure 8: Hemodynamic theory of CAVD 
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porcine AV leaflets showed that the fibrosa responded to non-physiological pulsatile WSS 
by an increase in the pro-inflammatory cytokines (TGF-β1 and BMP-4) expression, 
whereas exposure of the ventricularis to non-physiologic oscillatory WSS did not trigger 
any response [63]. Another ex-vivo study examined the influence of altered WSS 
magnitude and frequency on porcine AV leaflet tissue [64].  The study revealed an increase 
in BMP-4 and TGF-β1 expression under elevated WSS levels and an increase in ECM 
degradation under sub-/supra-physiologic WSS frequency (Figure 9), effectively 
demonstrating the sensitivity of AV leaflets to abnormal WSS. 
Figure 9: Pro-inflammatory state index (a) and remodeling state index (b) [64]
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1.10  Flow Characterization in the Aortic Valve and Coronary Arteries 
AV and coronary flows have been widely assessed in-vivo using magnetic 
resonance imaging (MRI) and echocardiography [65]–[68]. One MRI study showed the 
presence of vortices in the individual sinuses of the AV after peak systole, which persisted 
until diastole [69]. Similar techniques have been used for assessing the impact of increased 
arterial stiffness on coronary perfusion [70], [71]. In vitro studies have used various optical 
techniques to assess AV flow characteristics and WSS calculation in native and prosthetic 
valves. Laser doppler velocimetry (LDV) studies in mechanical valves showed the 
presence of high WSS on the ventricular leaflet surface subjected to pulsatile flow, and low 
WSS on the leaflet surface facing the aorta [72], [73]. Particle image velocimetry (PIV) 
measurements have also been carried out to characterize differences in sinus 
hemodynamics in different valve morphologies in terms of fluid shear stress and vorticity 
dynamics [74]. The study revealed the slow formation of vortices and the existence of 
higher shear stresses in the congenital BAV relative to the normal tricuspid aortic valve. 
The opening and closing mechanisms of the AV have also been investigated using PIV. 
One study subjected AV with different flow profiles by simply changing the duration of 
peak systole. Results showed that early peak systole, normally found in healthy individuals, 
instigated efficient valvular function when compared to late peak systole [75]. Clinical and 
experimental studies have been widely reported in the literature for the assessment of AV 
and coronary hemodynamics under normal blood pressure. However, there exists a lack of 
in-vivo and in-vitro data characterizing the flow in the AV under hypertension. 
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1.11  Computational Modeling of the Aortic Valve and Coronary Circulation 
In addition to medical imaging and in-vitro measurements, an alternative 
computational modeling method has been used to effectively characterize the 
hemodynamic environment of the AV and the coronary arteries. This approach also 
addresses the limitations of spatial and temporal resolution and data insufficiency, which 
is common in clinical and experimental techniques. 
1.11.1 Finite Element Method 
The finite element method (FEM) is a computational tool used to solve problems 
in solid-state mechanics. The basic concept of FEM is to divide the structural domain into 
discrete elements and solving the governing equation for each element. The global solution 
for the structure is obtained by combining the discrete solutions obtained from these 
elements. FEM studies of the AV have mostly looked at leaflet deformation and structural 
stresses developed in the leaflets [76]–[79]. One such study found that the non-coronary 
leaflet experienced the highest stresses of all three leaflets and that the maximum stresses 
were concentrated near the coaptation region [80]. FEM studies have also highlighted the 
importance of the sinus and valve geometry in reducing leaflet stress and strain distribution 
[81] and the role of aortic root compliance on valve opening [82], [83]. While FEM studies
are essential in structural analysis, they do not account for blood flow and are therefore not 
suitable for the assessment of leaflet WSS.  
1.11.2 Computational Fluid Dynamics Modeling 
Computational fluid dynamics (CFD) is a modeling technique that solves problems 
involving fluid mechanics. CFD predominantly uses the finite volume method (FVM) for 
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discretization. In FVM, the fluid domain is first discretized into several control volumes or 
cells. The Navier-Stokes equations are approximated on each of the cells using a cell center 
scheme. The physical quantities (e.g., velocity, pressure) are then computed on the node of 
each cell. Using cell centered interpolation profiles, these physical quantities are then 
derived for the whole fluid domain. CFD studies on the AV subjected to physiologic 
transvalvular pressure have investigated leaflet stresses during systole and have found 
regions of high stresses at the base of the leaflets [84]. CFD AV models have been mostly 
used to assess the velocity profiles, flow patterns, flow helicity and WSS characteristics on 
different AV morphologies and mechanical valves under normal blood pressure [85]–[88]. 
CFD studies have provided important information about AV flow features but neglect the 
interaction between the blood flow and the leaflets, which is a major drawback. 
1.11.3 Fluid-Structure Interaction Modeling 
Fluid-structure interaction (FSI) modeling is a computational technique modeling 
the interaction between a moving structure and a surrounding fluid flow. FSI modeling 
accounts for the transfer of momentum between a structure and a fluid, and therefore has 
been widely used to investigate valvular hemodynamics. FSI models can be developed 
using fixed-grid and moving-grid methods. In the fixed-grid method, separate grids are 
used for the discretization of the fluid and the structural domain. The fluid grid is fixed but 
the structural grid is free to move inside the fluid domain. Immersed boundary (IB) and 
fictitious domain (FD) methods are two implementations of the fixed-grid method. In the 
IB method, body force sources are introduced into the governing equations to account for 
the influence of the boundary. In the FD method, Lagrangian multipliers are used to couple 
the fluid and structural domains along the fluid-structure interface. Fixed grid methods 
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have been used to simulate AV hemodynamics [89]–[91]. However, in these methods, the 
grid does not fall automatically on the interface. Therefore, the precise location of the 
interface is approximated, which prevents accurate characterization of the leaflet WSS. 
The ALE method addresses those limitations by implementing a moving fluid mesh 
fitted to the moving boundary (Figure 10) [92]. While this method accurately tracks the 
location of the fluid-structure interface, large structural deformations may result in the 
degradation of the fluid mesh quality and the creation of negative cell volumes, which can 
result in convergence issues. Remeshing techniques can be utilized to prevent this issue by 
locally remeshing the cells in the fluid domain. 
 Two-dimensional (2D) [93], [94] and three-dimensional (3D) AV models [92], 
[95]–[97] have been used to simulate the native AV hemodynamics. FSI studies have also 
been used to investigate the valvular dynamics, the impact on the structural stress state [98] 
as well as the impact of nonlinear leaflet material [99] and AV asymmetry on the leaflet 
stress distribution [100]. A 3D FSI model previously developed in our laboratory 
characterized the global and regional WSS in AV leaflets [101]. The study reported a 
Figure 10: Fluid mesh in fixed grid method (a) and ALE method (b) [92] 
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surface-averaged leaflet WSS magnitude ranging from 5.8 to 19.9 dyn/cm2 on the fibrosa 
over a cardiac cycle. Another FSI study investigated the impact of coronary flow on AV 
hemodynamics and found that coronary flow caused an asymmetry in the sinus 
hemodynamics during diastole. Intense vortices were observed in the non-coronary sinus 
in comparison to the moderate vortices observed in the coronary sinuses. Results also 
showed up to 30% increase in time-averaged WSS (vs. no coronary flow model) on the 
fibrosa, demonstrating the crucial role played by the coronary circulation in AV 
hemodynamics [22]. 
1.12  Rationale for the Thesis 
Studies have demonstrated the crucial role played by WSS in valvular function and 
disease [64]. The increased expression of pro-inflammatory biomarkers reported under 
altered stress conditions has strongly highlighted the influence of abnormal hemodynamics 
in AV disease. Other studies aimed at characterizing hemodynamic stress alterations in 
structurally abnormal valves such as the BAV have revealed the existence of hemodynamic 
stress abnormalities on the leaflets as compared to the normal AV [101]–[103]. These 
studies have provided compelling evidence in support of the hemodynamic theory of 
CAVD. 
Hypertension is another important risk factor of CAVD. Studies have demonstrated 
the association between hypertension and CAVD, and have reported high level of incidence 
of hypertension in CAVD patients and vice versa [104]–[108]. A recent epidemiological 
study has reported that over 60% of hypertensive patients developed sclerosis and about 
5% developed AS [109], [43]. However, the mechanism by which hypertension may 
promote CAVD is still under debate. Numerous studies have suggested the existence of 
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abnormal AV hemodynamics under hypertension [110]–[114]. Other studies that have 
looked at the effects of  mechanical forces ( stretch, pressure, and fluid shear stress) on the 
remodeling activity of the valve have also suggested the existence of an abnormal 
hemodynamic environment under elevated pressure conditions [115]–[117]. An in-vitro 
study revealed that hypertensive conditions increased stretch magnitude on AV leaflets, 
which could in turn translate to leaflet dynamics and AV hemodynamic abnormalities 
[118]. Overall, these epidemiological and experimental studies suggest that hypertension 
may lead to altered AV hemodynamics, and ultimately CAVD pathogenesis. However, the 
AV hemodynamic environment under hypertensive conditions remains largely unknown. 
Studies characterizing AV hemodynamics and leaflet WSS under normal blood pressure 
are abundant in the literature but are almost nonexistent for hypertension. Hence, the 
objective of the present study is to investigate the impact of hypertension on valvular 
hemodynamics. The results of this mechanical investigation could be used in the future to 
test the validity of the hemodynamic theory of CAVD due to hypertension. 
To address this objective, the accurate assessments of the valvular flow 
characteristics and leaflet WSS environment are required. Medical imaging techniques 
have been used to measure the flow through the AV but are hampered by low spatial and 
temporal resolutions [119], [120]. In-vitro measurement techniques such as LDV and PIV 
have generated important data on leaflet WSS. However, LDV can only measure the three 
velocity components at a point in the flow field [121], [122]. Similarly, PIV can only 
capture the two velocity components in one flow section [123], [124]. Therefore, LDV and 
PIV are not suitable for the estimation of the spatial velocity gradients, and the assessment 
of the leaflet WSS distributions in a 3D flow environment. 
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 Computational modeling techniques such as FEM and CFD have been used in AV 
studies but are constrained to structural and fluid flow analysis, respectively, and are unable 
to account for the momentum transfer between the moving structure and the blood flow 
when used in isolation. FSI modeling overcomes this limitation and can provide accurate 
estimation of leaflet WSS as shown in previous studies. 
In addition to the potential impact of hypertension on AV flow, studies have also 
associated hypertension with altered ventricular function and increased ventricular work 
[54], [125], [126]. However, no quantitative data has been published on the impact of 
hypertension on LV overload. Similarly, the effects of hypertension on coronary flow have 
not been quantified. Therefore, this study aims at providing important information on the 
impact of hypertension on AV hemodynamics, left ventricular work and coronary flow 
using a FSI modeling approach. 
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CHAPTER 2: 
 SPECIFIC AIMS 
Hypertension is a common risk factor for CAVD but the mechanisms by which elevated 
pressure contributes to valvular pathogenesis remain largely unknown. The main 
hypothesis of this study is that hypertension generates flow alterations in the AV and WSS 
abnormalities on the valve leaflets, which may trigger CAVD pathogenesis. In addition, 
hypertension is also known to affect ventricular function and coronary flow, but the 
impacts of elevated blood pressure on ventricular mechanics and coronary flow regulation 
have not been elucidated. Hence, the focus of this study is to address the following research 
questions: Does hypertension affect the hemodynamic stress environment on the AV leaflets 
and, if so, to what extent? What is the impact of hypertension on coronary flow and the 
maintenance of myocardial perfusion? What is the impact of hypertension on left-
ventricular function?  
Therefore, the main objective of this study is to quantify computationally AV 
hemodynamics, coronary flow resistance and ventricular performance under 
normotensive and hypertensive conditions. Three specific aims are developed to fulfill 
this objective:
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Specific aim 1: To develop and validate a computational model for characterizing 
valvular flow under normotensive condition 
In this aim, a FSI model featuring a realistic AV and aortic root, and including the coronary 
arteries was designed to simulate valvular flow under normotensive condition. A 
previously validated coronary-AV geometry was improved to achieve realistic valvular 
motion and to ensure computational stability. Boundary conditions representing 
physiologic cardiac output, blood pressure and coronary perfusion were applied to the 
model. A FSI modeling strategy based on the ALE method was adopted to account for the 
interactions between the moving leaflets and blood flow, and for mesh motion. The blood 
and the leaflets were modeled using a Newtonian incompressible fluid and a hyperelastic 
Mooney-Rivlin material formulation, respectively. The model was validated by comparing 
the predicted flow field, leaflet dynamics and WSS characteristics with previously 
published clinical, experimental and computational data. 
Specific aim 2: To quantify AV hemodynamics and leaflet dynamics under 
hypertensive conditions 
The main focus of this aim was to characterize AV hemodynamics under prehypertensive 
and stage-1 hypertensive conditions and to compare it with the predictions obtained in the 
normotensive model of Aim 1. The computational framework developed in Aim 1 was 
modified to incorporate prehypertensive and stage-1 hypertensive boundary conditions. 
The same physiologic coronary flow as that implemented in the normotensive model was 
maintained in these models to account for coronary remodeling and the maintenance of 
myocardial perfusion. The flow structure, leaflet WSS characteristics and leaflet dynamics 
25 
were compared to those predicted in the normotensive model to elucidate the impact of the 
degree of hypertension on AV function and mechanics. 
Specific aim 3: To investigate the effects of hypertension on coronary resistance and 
LV workload  
The objectives of this aim were to explore the cause-and-effect relationships between 
hypertension and 1) coronary remodeling as quantified by alterations in coronary 
resistance, and 2) ventricular hypertrophy as quantified by increased ventricular workload. 
To quantify the effects of hypertension on coronary flow resistance, the models from Aim 
1 and Aim 2 were revisited and flow resistance in the coronary arteries was evaluated under 
normotensive, prehypertension and hypertension conditions. To assess the effects of 
hypertension on LV workload, the models were further analyzed to obtain the LV pressure-
volume curves and quantify the work done by the LV under normotensive, prehypertensive 
and stage-1 hypertensive conditions. 
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CHAPTER 3: 
 SPECIFIC AIM 1: To develop and validate a computational model for characterizing 
valvular flow under normotensive condition 
The focus of this aim was to design the coronary-AV model, and to establish appropriate 
modeling strategy and methodology to simulate valvular flow under normotensive 
conditions. The predicted AV hemodynamic and leaflet mechanical characteristics were 
also compared with those found in the literature for validation purpose. The methodology 
included the reconstruction of the valve geometry, the generation of the mesh, the 
formulation of the material model, the numerical formulation of the FSI problem, and the 
development and prescription of appropriate boundary conditions for the normotensive 
case. AV hemodynamics was assessed in terms of flow characteristics, leaflet WSS and 
stretch ratios.  
3.1.  Methodology 
3.1.1. Previous Coronary-AV model 
A coronary-AV model previously designed in our laboratory was taken as 
a foundation for the development of the improved model used in this thesis. This 
section describes the previously published model.
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3.1.1.1.   Valve Geometry 
  The valve geometry consisted of three identical leaflets housed in the aortic root, and 
the two coronary arteries with extended inlet and outlets [101]. The leaflets, the aortic 
sinuses and the coronary arteries were constructed using published human AV dimensions 
consisting of the diameters for the aortic and ventricular section, the aortic wall thickness, 
the sinus height and diameter, and the height of the leaflets from the aortic annulus (Table 
3) [98], [127]. The spatial variation of the leaflet thickness from the base to the tip was also
incorporated in the geometrical model (Table 4) [80]. Different geometric guides such as 
the tip point, leaflet centerline, commissure point and annulus point were created based on 
the above dimensions (Figure 11a [128]). The aortic wall and the leaflets were designed in 
SolidWorks using these guides. Surface features were utilized to first generate one half of 
the aortic root and a leaflet, and a full AV geometry with all three leaflets and the full aortic 
root was then obtained by using the mirror function (Figure 11b). The coapted leaflet 
position was considered as the starting stress-free state. The coronary arteries (LCA and 
RCA) were incorporated in the full AV model, with coronary ostia located 18-mm above 
the aortic annulus, as reported in vivo [129]. The LCA and RCA were modeled with 
diameters of 4 mm and 3.2 mm, respectively [129], a thickness of 0.4 mm [130], and their 
outlets were extended by 6 mm from the aortic wall (Figure 11c). 
Table 3: AV dimensions (mm) 
ra rv ds hs hl ta ts tv 
12.5 12.5 6.0 22.1 14.0 1.5 1.5 1.5 
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free edge nodulus of 
Aranti
1.16 0.18-0.58 0.68-1.29 1.53 2.06 
3.1.1.2.  AV Leaflet and Blood Constitutive Models 
As a first approximation, the leaflet material was modeled as isotropic and 
homogenous. Collagen fibers on the AV leaflets are known to exert extra stiffness at 
increased stress in the circumferential direction, causing the non-linear hyperelastic strain-
stress response of the leaflets. Therefore, a three-parameter Mooney-Rivlin material model 
was used to approximate the leaflet mechanical behavior. The strain energy density 
function for a three-parameter Mooney-Rivlin material is given by    
Figure 11: Base Geometry: (a) one-sixth AV model with dimension parameters, (b) 
sectional view of full AV geometry without coronary arteries and (c) top view of 
the coronary AV geometry [128]
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where 1I  and 2I  are the two invariants of the Cauchy-Green deformation tensor, and 10C , 
01C  and 11C  are material constants calibrated from experimental tensile data obtained from 
the literature [131]. The stress-strain curve of the leaflet material predicted by this model 
closely matched the response measured experimentally on porcine leaflets (Figure 12 
[128]).  
A fluid density of 1050 kg/m3 and dynamic viscosity of 0.0035 Pa·s were adopted to 
approximate blood as a Newtonian, homogenous and incompressible fluid. This 
approximation is consistent with several other computational studies on valvular and 
vascular blood flow [99], [102], [132].  
Figure 12: Stress vs strain curve of the leaflet material [128] 
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3.1.1.3.  Boundary Conditions 
Flow in the AV was simulated using a near-physiologic transvalvular pressure 
profile ranging from 6 mmHg to -94 mmHg at the valvular inlet [128] and zero-gauge 
pressure at the outlet. An FSI interface with no-slip condition was set up on the fluid 
surfaces in contact with the leaflets.  The structural inlet and outlets were fixed to avoid 
longitudinal motion. An arbitrary mechanical pressure ranging from 0 to 23 mmHg (3 kPa) 
was also imposed on the leaflets during diastole to ensure coaptation. A three-parameter 
Windkessel model was applied to the coronary outlets to prescribe physiologic coronary 
volume flow rates (LCA: 0.2 L/min and RCA: 0.05 L/min) during the cardiac cycle [22].  
3.1.2. Improved Coronary-AV Model 
The model described in the previous section was modified to more accurately 
simulate the native valvular flow and the leaflet deformation under normal pressure 
conditions. This section describes the improvements made to the previous model. 
3.1.2.1.   Valve Geometry 
The new geometry implemented the same overall AV dimensions and leaflet 
thickness as in the previous model. Changes were made to improve leaflet coaptation and 
numerical stability. In the previous model geometry, the starting position of the leaflets led 
to a large gap between the leaflets and improper coaptation during diastole. This issue was 
addressed in the new model by increasing the leaflet free-edge length by 1.2 mm in the 
radial direction. This geometrical change was achieved practically by displacing the tip 
point and the centerline by 1.5 mm towards the center of the valve (Figure 13). The new 
leaflet position was considered as the initial stress-free state. In addition, the aortic and 
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coronary outlets were further extended to 36 mm and 20 mm, respectively (original: 12 
mm and 6 mm, respectively), to let the flow develop and improve computational stability. 
The improved AV geometry was designed using SolidWorks 2018 (Dassault Systemes 
SE). 
3.1.2.2.  Boundary Conditions 
Boundary conditions were specified to simulate valvular flow under normotensive 
conditions. A transient and spatially uniform velocity profile calculated from the 
physiologic aortic flow rate waveform [133] was prescribed at the valve inlet (Figure 14), 
and resulted in a cardiac output of 5 L/min and a systolic-to-diastolic ratio of 1:2.  
Figure 13: Coronary AV geometry: (a) side view showing aortic outlet extension, (b) 
top view showing extended LCA and RCA outlets (c) one-sixth sectional view of the 
aortic root showing the displaced tip point and the centerline 
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The implementation of the new boundary conditions allowed the aortic outlet to be set 
at constant zero-gauge pressure to mimic the native hemodynamic environment, which 
contrasted with the previous model which imposed a transvalvular pressure gradient. The 
forward flow momentum generated by the inlet conditions allowed the passive opening of 
the leaflets during systolic ejection. However, the lack of negative transvalvular pressure 
imposed during diastole resulting from this strategy had to be compensated for by 
subjecting the aortic leaflet surface to a physiologic diastolic pressure (0 – 80 mmHg, 
Figure 15), in order to ensure leaflet coaptation. 
An FSI interface with a no-slip condition was set up on the fluid surfaces in contact 
with the leaflets. Coronary flow velocities calculated from published physiologic coronary 
volume flow rates (LCA: 0.2 L/min and RCA: 0.05 L/min) [134], were specified at the 
coronary outlets (Figure 16). 
Figure 14: Inlet velocity profile 
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In the structural setup, the aortic wall was considered rigid to save computational time. 
The leaflet surface was defined as a fluid-structure interface and the leaflets were prevented 
from penetrating each other during closure by implementing a frictionless contact with a 
contact offset of 0.5mm.  
Figure 15: Mechanical pressure on the leaflet fibrosa 
Figure 16: Coronary flow velocity profiles 
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3.1.3. Mesh Generation 
The structural and fluid domains were spatially discretized using tetrahedral elements 
in ANSYS R19.3. The structural grid consisted of 48,516 elements, which was shown to 
be sufficient to yield mesh-independent results in a previous study [22]. For the fluid 
domain, a mesh sensitivity analysis was performed to obtain a final computational grid of 
629,284 elements (Table 5). The fluid domain was exported at peak systole and was 
meshed with different cell sizes. The resulting fluid grids were then used to run a steady-
state CFD simulation representative of the peak-systolic conditions. The endpoints 
considered to assess numerical convergence included the average velocity captured at a 
point located 21 mm downstream of the inlet, the TPG across the valve, and the surface-
averaged pressure exerted on the NCL. Simulations using the fourth grid size resulted in 
less than 1% change in parameter values as compared to the previous grid size. Therefore, 
the third grid (average cell size: 0.64 mm; number of elements: 629,284) was chosen as the 
final grid size for the fluid domain. 











1 1.00 162604 0.73 21.09 173.84
2 0.75 452000 0.69 31.46 169.23
3 0.64 629284 0.67 27.17 164.78
4 0.55 926672 0.67 27.19 163.80
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3.1.4. FSI Modeling Strategy 
The investigation of the impact of hypertension on leaflet dynamics required the 
accurate assessment of the transfer of momentum between blood flow and the leaflets, 
which was fulfilled by employing a FSI modeling strategy. In this approach, the mechanical 
data is transferred between the fluid and solid domains through an intermediate system 
coupling. The fluid domain transfers force to the structural domain and the resultant 
displacement is transferred back to the fluid domain, thereby performing a two-way FSI 
coupling (Figure 17a [135]). The cycle was repeated iteratively until a converged solution 
was reached for the fluid and structural governing equations, and the system coupler at 
every time step (Figure 17b [136]).   
Figure 17: Schematic showing 2-way FSI modeling (a) [135] and three levels of 
iteration in a transient 2-way FSI simulation (b) [136]
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3.1.4.1.   Fluid Domain Description 
The governing equations for the fluid domain consisted of the momentum and continuity 
equations. The fluid flow equations were formulated in the ALE form as shown below: 
(( ) )f f f
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are the velocities of the fluid and moving grid respectively.
The transient flow solution was solved in ANSYS Fluent, which implements a 
FVM to discretize the governing equations. Briefly, the domain is first divided into cells. 
The governing equations are then integrated in each cell to create algebraic equations 
known as discretization. Finally, the algebraic equations are linearized, and a pressure-
based solver is used to solve the equations iteratively and to update the fluid pressure and 
velocity fields.  
3.1.4.1.1.  Discretization of Momentum Equation 
The unsteady transport equation of a scalar quantity ( ) expressed in an integral form 
can be discretized for a given cell volume V as 
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where N is the number of faces surrounding the cell, f  is the convection component of   
through the face, fv

 is the face velocity vector,   is the diffusion coefficient for  , fA

is
the face area ( ˆ ˆx yA A i A j  in 2D), f  is the facial gradient and S  is the source of   
per unit volume. The nonlinear terms in equation 4 are linearized using coefficients p , 
nba  and b  for  , nb  and p  , respectively, to yield the following equation: 
p nb nb
nb
a b    ,  (5) 
where nb refers to the neighboring cells and P refers to cell center. Equation 5 is then 
applied to all cells in the mesh to get algebraic equations with sparse coefficient matrix.  
The momentum equation was similarly discretized by substituting   with the velocity 
component of the respective momentum equation. For example, the x-momentum equation 
is expressed by substituting   with x-velocity component u as shown below: 
ˆ
p nb nb f
nb
u a u A i S     

,  (6) 
where ˆA i

 is the face area vector component and S  is the source term. The velocity field 
can be calculated from this equation if the pressure and face mass flux are known. Like the 
scalar quantity  , these values were represented at the cell centers and not at the faces, 
which required the use of interpolation schemes. For pressure interpolation, a second-order 
upwind scheme was used. The governing equations were also discretized temporally using 











3.1.4.1.2.  Discretization of Continuity Equation 






J A  ,  (8) 
where fJ  is the mass flux through f . 
The weighing factors obtained from equation 6 were used in a momentum-weighted 
averaging-based interpolation scheme to obtain the normal face velocity ( nv

). The face
flux was then expressed as: 
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v represent the pressure and normal velocity component, 




 are the distance from the face
to respective cell centers and fd  accounts for the averaged coefficients pa  from equation 
6. 
The discretized governing equations were solved iteratively using a pressure-based 
solver. An additional pressure condition was developed by correcting the continuity 
equation. This corrected pressure equation was used for pressure-velocity coupling. The 
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coupled algorithm, which solves the momentum and pressure-based continuity equations 
together, was selected as the solver (Figure 18 [137]). The coupled algorithm allows for 
faster convergence and is highly adaptable to poor mesh quality during the simulation 
compared to other solvers. The solver iteration ended once the convergence residual of 
0.001 was reached for the pressure and velocities in the momentum equations.
Due to the dynamic nature of the fluid mesh, smoothing and remeshing settings were 
enabled. Spring-based smoothing with a factor of 1 was enabled to move the interior nodes 
relative to the boundary nodal displacement. A remeshing strategy was utilized to account 
for the degradation of cells due to the large displacement of the boundary. Without 
remeshing, the deteriorated cells can cause negative cell volume and convergence issues. 
Cells below a certain size and skewness criterion were locally remeshed, and the new cells 
that were formed were checked for the same criteria to maintain mesh quality throughout 
the simulation. 
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3.1.4.2.  Structural Domain Description 
The structural domain was governed by the momentum equation expressed in 
Lagrangian form as: 
s s s sd f   
  , (10) 
where s  is density of the structure, sd

are displacement, s  is stress tensor and sf

 is body
force per unit volume. 
The displacements were solved in ANSYS Mechanical, which uses FEM to spatially 
discretize the principle of virtual work, and to develop the finite-element semi-discrete 
equation of motion as 
Figure 18: Overview of the pressure-based coupled algorithm [137] 
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       Mu t Cu t Ku t F t  
    ,  (11) 
where M , C  and K  are the structural mass, damping and stiffness matrix, respectively, 
 u t ,  u t and  u t are the nodal acceleration, velocity and displacement vector,
respectively, and  F t

 is the external load vector.
Equation 11 was time-integrated using the Newmark method and was reformatted as 
1 1 1 1n n n nMu Cu Ku F     
    ,  (12) 
where 
 1 11n n n nu u u u t        





2n n n n n
u u u t u u t  
            
       ,  (14) 
Equations 12, 13 and 14 were combined together to replace the integration parameters 
 and   with parameters 0a  to 7a , and form the single-step time integrator with one 
unknown and three known quantities: 
     0 1 1 1 2 3 4 5 6 7n n n n n n n na M a C K u F M a u a u a u C a u a u a u                   ,  (15)
1nu  was calculated from above and its time derivatives (i.e., velocity and 
acceleration vectors) were then calculated using the following equations: 
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 1 1 1 4 5n n n n nu a u u a u a u    
       ,  (16) 
 1 0 1 2 3n n n n nu a u u a u a u    
       ,  (17) 
Equations 15 to 17 were solved iteratively at every time step using the Newton 
Raphson method, until the convergence criterion were achieved. The convergence criterion 
was based on the product between the default tolerance value ( 0.001R  ) and the reference 
value ( refR ) obtained from the total applied force: 
R refR R  ,  (18) 
3.1.4.3.  System Coupling 
The transfer of data between ANSYS Fluent and Mechanical was achieved via the 
system coupling module System Coupler 1.0. Three coupling conditions were enforced to 
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   
 
  , (19) 
where ˆsn and ˆ fn  are the normal unit vectors at the interface for the structure and fluid 
domain, respectively. Coupling iterations were also checked for convergence at every time 
step. This was achieved when the difference between two successive data transfers fell 
below 10-3 for both displacement and force. The minimum and maximum number of 
coupling iterations were set to 20 and 50 respectively. The simulation end time was 1.72 
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seconds to span two cardiac cycles, and a time-step size of 10 ms was adopted to discretize 
each cycle into 86 time steps. 
ANSYS Workbench provided a platform to run all the solvers and the coupling module. A 
detailed representation of the FSI solution procedure is shown in Figure 19 [136]. 
Figure 19: Schematic showing the 2-way FSI solution procedure [136] 
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3.1.5. Mechanical Characterization 
At the end of the simulations, the results were post-processed and the AV 
hemodynamics, leaflet WSS environment and the leaflet dynamics were characterized 
using different metrics. 
3.1.5.1.  Leaflet Dynamics 
Valvular dynamics was characterized in terms of the geometric orifice area (GOA), 
which is the anatomical orifice area of the valve at peak systole. It was computed by 
measuring the area of the planar region connecting the lowest points of the free edge of the 
leaflets (Figure 20a). Leaflet deformation was qualitatively investigated by comparing the 
leaflet profile predicted at different phases of the cardiac cycle. The coapted configuration 
of each leaflet in the model was also quantified by calculating a coaptation leaflet angle 
defined as the angle between the line tangent to the base of the leaflet and the horizontal 
direction (, Figure 20b). Lastly, AV mechanics was also assessed in terms of the leaflet 
stretch ratio ( ), which represents the ratio of the deformed length ( l ) to the initial length 
( L ) of a line element aligned along a particular direction: 
l
L
  (20) 
The stretch ratios in both radial and circumferential directions were assessed regionally and 
globally for all three leaflets. 
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3.1.5.2.  Valvular Hemodynamics and WSS Characteristics 
The velocity field was assessed in terms of the streamline field and the in-plane 
vorticity field captured in the three vertical planes bisecting the leaflets (Figure 21a). The 
EOA, peak systolic jet velocity and mean pressure gradient were also quantified. The EOA 








where Q is volume flow rate in mL/s, and P  is the transvalvular pressure gradient in 
mmHg. 
The WSS distribution on the leaflets was characterized qualitatively by capturing 
the WSS contours and WSS waveforms and quantitatively in terms of temporal shear 
magnitude (TSM) and oscillatory shear index (OSI). The TSM represents the time-
averaged WSS magnitude, while the OSI indicates the directionality of the WSS, with a 
Figure 20: GOA measurement plane (a) and leaflet opening angle 
measurement scheme (b) 
46 
value of 0 representing unidirectional/pulsatile flow and a value of 0.5 representing a 
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respectively, where τ is the instantaneous WSS, and T is the cardiac period, were 
computed in the tip, belly and base regions of each leaflet for both the radial and 
circumferential WSS components (Figure 21b). 
Figure 21: Leaflet planes for vorticity field assessment (a) and leaflet 
regions with the radial and circumferential direction (b) 
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3.2  Results 
The model was run to simulate two cardiac cycles. The results were analyzed for 
temporal convergence and the converged results were extracted for further post-processing. 
3.2.1.  Normotensive AV Hemodynamics 
The normotensive model generated a peak-systolic jet velocity of 1.15 m/s, a mean 
systolic pressure gradient of 3.46 mmHg and an EOA of 3.84 cm2. The transvalvular 
pressure across the valve during the cardiac cycle was also computed (Figure 22) and the 
time-averaged pressure gradient was found to be -10.65 mmHg. 
Snapshots of the streamline field was captured throughout the cardiac cycle (Figure 
23). The acceleration phase was marked by the opening of the valve leaflets due to the 
increase in transvalvular pressure. As the leaflets opened, there was an increase in flow 
velocity through the valve orifice. Peak systole was associated with the maximum flow 
Figure 22: Transvalvular pressure vs. time in the normotensive model 
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velocity (1.15 m/s) and the maximum opening of the leaflets (GOA: 4.47 cm2). During this 
phase, the flow in the sinus region was almost stagnant as the deployment of the leaflets 
trapped the blood located within the three aortic sinuses. Streamlines also showed that until 
peak systole, coronary flow was reduced due to the myocardial contraction. During the 
deceleration phase, the drop in pressure gradient led to a reduction in orifice jet velocity 
(36% vs peak systolic velocity) and the rapid closure of the leaflets (24% decrease in GOA 
vs peak-systole). Coronary flow velocity showed a slight increase during this phase. During 
diastole, the leaflets were fully closed and coapted due to the combination of the negative 
transvalvular pressure and the external mechanical pressure applied on the leaflets. 
Increased flow velocity was observed during this phase for both LCA and RCA, which 
slowly dissipated by the end of diastole.   
Figure 23: Streamline field during the acceleration phase (t=80 ms), at peak systole 
(t=130 ms), during deceleration phase (t=230 ms) and during diastole (t=400 ms) 
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The in-plane vorticity contour and velocity vector fields were captured in the 
vertical planes bisecting the leaflets during the acceleration phase, at peak systole, during 
deceleration phase and during diastole (Figure 24). The vorticity contours captured 
downstream of the three leaflets were largely similar throughout the acceleration phase 
until peak systole (t=130 ms). During the deceleration phase, the combination of flow 
deceleration and leaflet bending led to vortex shedding and formation of high-magnitude 
counterclockwise vortices near the tip of all three leaflets. These vortices are known to 
promote valve closure [19], [20]. During early diastole, the tip vortices migrated 
downstream of the valve into the aorta and the coronary arteries. This phase was also 
characterized by decrease in vorticity magnitude in the sinus region behind the leaflets. 
During the rest of diastole, the vortices in the sinuses and downstream of the valve slowly 
dissipated. The size and magnitude of the tip vortex slightly varied between the leaflets, 
with the LCL and RCL generating stronger vortices than the NCL during the deceleration 
phase. The vorticity captured near the belly and base regions of the LCL also exhibited 
higher magnitude than those captured in the same regions of the RCL and NCL. This 
observation is supported by the calculation of the plane-averaged vorticity, which revealed 
a 9.5-fold increase in the LCL plane relative to the NCL plane, and a 9.1-fold increase in 
the NCL plane relative to the RCL plane.  
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Figure 24: Vorticity and velocity field in the leaflet bisecting planes during the 
acceleration phase (t=80 ms), at peak systole (t=130 ms), during deceleration 
phase (t=230 ms) and during diastole (t=400 ms and t=560 ms) under 
normotensive condition 
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3.2.2.  WSS Characteristics 
The spatial WSS distribution on the fibrosa was captured on each leaflet at five 
phases during one cardiac cycle (Figure 25). During the acceleration phase, high WSS 
levels were concentrated in the tip of all three leaflets, while a second region of elevated 
WSS was also observed near the axis of symmetry of the NCL in the base and belly (1). At 
peak systole, the WSS levels predicted in the tip, belly and base of the leaflets were lower 
than those captured during the acceleration phase. Increased WSS levels were mostly seen 
in the tip of the leaflets with the LCL and NCL contour displaying regions of increased 
WSS levels on and in the vicinity of the axis of symmetry (2). During the deceleration 
phase, the LCL and RCL exhibited relatively similar WSS distributions marked by several 
pockets of elevated WSS along the free edge (3). While those pockets were also present in 
the NCL (4), they were typically larger in size and characterized by higher WSS magnitude. 
As expected, the progressive loss of flow momentum during diastole was accompanied by 
a marked reduction in WSS on the leaflets, and the attenuation of the differences observed 
earlier.  
The temporal WSS variations over the cardiac cycle were extracted along the radial 
(Figure 26) and circumferential directions (Figure 27). These waveforms exhibited the 
typical low-oscillatory nature of the WSS environment on the leaflet fibrosa [64], [138], 
[139]. Regardless of the leaflet, the highest radial WSS levels were predicted in the tip 
region. In contrast, the circumferential WSS waveform did not show any regional 
variations in WSS level on the leaflets. Highest radial WSS oscillations were observed in 
the base region of leaflets, especially NCL. Unlike the radial WSS waveform, the tip and 
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belly region of the leaflets showed high frequency of WSS oscillations in the 
circumferential direction. 
Figure 25: WSS distribution in the LCL, RCL and NCL fibrosa during the acceleration 
phase (t=80 ms), at peak systole (t=130 ms), during deceleration phase (t=230 ms) and 
during diastole (t=400 ms and t=560 ms) with four specific regions 
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Figure 27: Radial WSS waveform in the tip, belly and base of the LCL, RCL and NCL 
fibrosa for the normotensive case 
Figure 26: Circumferential WSS waveform in the tip, belly and base of the LCL, RCL 
and NCL fibrosa for the normotensive case 
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The temporal radial and circumferential WSS characteristics were quantified in 
terms of TSM and OSI as reported in Table 6 and Table 7, respectively. Since the flow 
direction is dominant in the radial direction on the fibrosa, the radial component of WSS 
was expected to be dominant and higher compared to the circumferential component. As 
compared to the LCL, the RCL and NCL displayed 2% and 6% increase, respectively, in 
leaflet-average radial TSM. The radial TSM increased from the base to the tip of the leaflets 
(LCL: 16- and 2-fold increase; RCL: 19- and 2.5-fold increase; NCL: 12.3- and 1.5-fold 
increase in the tip and belly, respectively, vs. the base). The leaflet-average circumferential 
TSM in the RCL and NCL was 10% and 4% lower than that computed on the LCL, 
respectively. Following the trend of the radial TSM, the circumferential TSM increased in 
the tip region of the leaflets (LCL: 50% increase; RCL: 60% increase; NCL: 110% 
increase) relative to the base. The predictions of the circumferential TSM in the belly 
region exhibited an opposite trend (LCL: 40% decrease; RCL: 13% decrease; NCL: 8% 
decrease relative to the base). The analysis of the OSI in the radial direction revealed the 
oscillatory nature of the flow near the leaflet belly and base regions (OSI > 0.24), which 
contrasted with the pulsatile flow characteristics captured near the tip (OSI < 0.15). The 
circumferential OSI exhibited pulsatile flow characteristics near the belly and base regions 
(OSI < 0.17) and oscillatory flow characteristics near the tip (OSI > 0.29).  
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Table 6: Radial TSM and OSI in the regions of LCL, RCL and NCL 
Leaflet TSM (Pa) OSI
tip belly base tip belly base
LCL 1.29 0.16 0.08 0.14 0.32 0.24
RCL 1.32 0.17 0.07 0.14 0.29 0.44
NCL 1.35 0.16 0.11 0.15 0.38 0.28
Table 7: Circumferential TSM and OSI in the regions of LCL, RCL and NCL 
Leaflet TSM (Pa) OSI
tip belly base tip belly base
LCL 0.12 0.05 0.08 0.33 0.15 0.12
RCL 0.11 0.06 0.07 0.29 0.17 0.13
NCL 0.13 0.06 0.06 0.43 0.10 0.12
3.2.3.  Leaflet Dynamics 
The model predicted a GOA of 4.47 cm2. Leaflet deformation profile was also 
visualized during the cardiac cycle (Figure 28). LCL and RCL profiles showed no 
qualitative differences throughout the cardiac cycle. NCL profile differed from the other 
leaflets only during the deceleration phase.  
56 
The maximum leaflet opening angle of 87.4 was detected at peak systole. The 
calculation of the leaflet coaptation angle (Table 8) revealed nearly similar coaptation 
profiles on the three leaflets.  
Table 8: Leaflet coaptation angle under normotensive condition 
Leaflet type LCL RCL NCL 
Angle of the leaflet (θ) in 
degrees
27.14 27.08 27.01
Radial and circumferential leaflet stretch ratios were evaluated and reported in Table 
9. The leaflet-average radial stretch ratio in the RCL and NCL was found to be 5% and 2%
higher than that predicted in the LCL, respectively. The leaflet-average circumferential 
stretch ratio was also 4% and 1% higher in the RCL and NCL, respectively, than in the 
LCL. The radial stretch ratio increased from the base to the tip of the RCL (8% and 9% 
Figure 28: Leaflet profiles at peak systole (green), during the deceleration phase 
(red) and during diastole (blue) under normotensive condition 
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increase, respectively, vs. the base). LCL and NCL showed almost uniform stretch across 
the surface with less than 1% change in the radial stretch characteristics. The 
circumferential stretch in the RCL was increased by 7% each in the tip and belly vs. the 
base. NCL displayed 2% increase only in the tip vs. the base. LCL showed no variation 
across the surface.  
Table 9: Regional stretch characteristics on AV leaflets 





LCL 1.01 1.01 1.00 1.01 
RCL 1.08 1.10 1.00 1.06 




LCL 1.01 1.00 1.00 1.00 
RCL 1.07 1.07 1.00 1.05 
NCL 1.02 1.01 1.00 1.01 
The systolic-average and diastolic-average stretch characteristics were also 
computed to quantify the increase in stretch during coaptation (Figure 29). Both the radial 
and circumferential stretch ratio were increased from the base to the tip region. The radial 
stretch was predominant in all the leaflets. Radial diastolic stretch was increased by 32%, 
24% and 38% in the LCL, RCL and NCL, respectively, vs the systolic stretch ratio. 
Similarly, circumferential stretch ratio during diastole was increased by 25%, 19% and 









Figure 29: Regional stretch characteristics on AV leaflets during systole and 
diastole 
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3.3.  Discussion 
The discussion section includes the comparison of flow characteristics, WSS 
environment and leaflet mechanics between the normotensive model of this study with the 
data reported in literature as well as the previous coronary-AV model. Lastly, the 
limitations of the computational model are also broadly discussed.   
3.3.1. Model Validity 
The objectives of this first aim were to develop a validated AV computational model 
subjected to normotensive conditions, and to generate a reference valvular mechanical 
state. The approach consisted of refining a previously published AV geometry including a 
functional coronary flow model, and running FSI simulations to predict the flow and the 
leaflet dynamics under normotensive conditions and physiologic CO.  
AV hemodynamics was characterized by a high velocity flow during the ejection phase 
followed by the formation of intense vortices, characterized by strong flow rotationality, 
near the tip region of the leaflets during the deceleration phase. Coronary flow resulted in 
the suppression of the tip vortices in the left- and right-coronary sinuses during this phase. 
The diastolic phase was characterized by a reduction in valvular flow, vortices migration 
downstream into the coronary arteries and aorta and its progressive dissipation. These 
characteristics are in agreement with other valvular and coronary flow characterizations 
reported in computational [98], [128] and in-vitro studies [140], [141]. The predictions of 
key flow parameters, such as the mean TPG (3.46 mmHg), peak-systolic jet velocity (1.15 
m/s) and EOA (3.84 cm2), were consistent with clinical and experimental data [33], [68], 
[97], [142]–[146] (Table 10).  
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Table 10: Validation of normotensive flow metrics 
Flow metrics FSI model Literature 
Peak systolic jet velocity (m/s) 1.15 <2 
Mean pressure gradient (mmHg) 3.46 <5 
EOA (cm2) 3.84 3-4
Regardless of the leaflet, the WSS captured on the fibrosa was found to be low-
magnitude and oscillatory in the base and belly regions. Consistent with previously 
published data [73], [128], the WSS predicted on the fibrosa ranged from 0 to 4 Pa 
(literature: 0-3.5 Pa), and exhibited increasing magnitude from the base to the tip of the 
leaflets. The radial TSM was dominant (one-order of magnitude difference) over the 
circumferential TSM on the leaflets, which is consistent with the literature [73], [102], 
[128]. The effects of the coronary circulation on the leaflet WSS environment were 
suggested by the substantial differences in spatial WSS distribution and WSS magnitude 
predicted between the NCL and the LCL/RCL. TSM and OSI predictions also exhibited 
increased values in the NCL relative to the LCL/RCL.  
Additionally, the GOA, leaflet opening angle and stretch ratios were assessed and 
compared with published data to validate the leaflet mechanics. The model estimated a 
GOA of 4.47 cm2, which fell within the range of 3-5 cm2 reported by clinical studies [147], 
[148]. The maximum leaflet opening angle (87.4) was also consistent with the range 
reported in the literature (85-94) [149], [150]. Stretch ratios increased from the base to the 
tip of the leaflets, and the radial component was found to be slightly larger and dominant 
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by 2% over the circumferential stretch, consistent with previous reports [101], [118]. The 
present coronary-AV model was able to capture the native flow and WSS environment and 
the leaflet mechanics under normotensive condition. Overall, these characteristics 
demonstrated the validity of the present model to simulate physiologic blood flow and 
leaflet deformation under different pressure conditions. 
3.3.2. Model Improvements vs. Previous Models 
The present coronary-AV model was developed from a previous model with 
improvements made to the geometry and boundary conditions. These improvements 
resulted in the following mechanical variations:    
 Increase in the leaflet free-edge length enabled coaptation with reduced gap
between the leaflets during diastole (26.5% lower) relative to the previous model
 Extension of the valve and coronary outlets helped in flow development and
numerical stability
 The use of velocity profile at the inlet enforcing a physiologic CO of 5 L/min
resulted in a GOA of 4.47 cm2 mimicking native valve function more closely than
the previous model, which generated a CO of 4.3 L/min and a GOA of 3.7 cm2
 Leaflet closure was achieved by subjecting the leaflets to a diastolic pressure
condition of 80 mmHg matching the native aortic pressure value. This improvement
over the previous model, which implemented a non-physiologic pressure of 22.5
mmHg, resulted in near-native leaflet deformation during diastole
The improvements made in the present model allowed for the generation of physiologic 
leaflet deformation and flow characteristics in the AV. Overall, a computational coronary-
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AV model capable of simulating native blood flow under normotensive condition was 
developed, and successfully validated using different qualitative and quantitative 
measures. Hence, this model was used as a reference model in the subsequent aims. 
3.3.3. Limitations 
A number of simplifications were made to the model and the methodology. These 
simplifications were consistent to the ones considered in other computational studies [92], 
[101], [128], [151]–[153].  
The main limitations are the use of an approximated leaflet material and the 
prescription of a zero outlet gauge pressure instead of the physiologic aortic pressure 
profile. The anisotropy of the leaflet material due to the orientation of the elastin and 
collagen fibers was neglected. Instead, the leaflet material was assumed isotropic in order 
to prevent structural element distortion. This assumption was justified as results from a 
previous study implementing an isotropic model [128] showed only limited differences in 
leaflet mechanics relative to models implementing an anisotropic leaflet material [154], 
[155]. However, flow resistance is dependent on the leaflet material, which is hindered due 
to this approximated leaflet model. Therefore, to achieve the CO of 5 L/min, a constant 
non-physiologic zero-gauge pressure was used, effectively subjecting the valve to a non-
physiologic transvalvular pressure gradient. This difference between the native 
transvalvular pressure and the transvalvular pressure captured by the model is essential in 
achieving the physiologic CO under normotensive condition.  
Secondly, the valvular geometry was designed with three identical, equiangularly 
spaced sinuses and leaflets. This is a simplification of the native aortic root, which consists 
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of non-identical leaflets and sinuses, and generates leaflet-specific stress environments 
[80]. Hence, improving the valve geometry should be addressed in a future model.  
Blood flow in the native AV transitions from laminar to turbulent at peak systole. 
However, the flow was modeled as laminar. This assumption was made to limit the 
complexity of the FSI model, and reduce computational time and cost. A justification for 
this assumption was also provided by a previous computational study that found no 
substantial difference in overall flow structure between a laminar and a turbulent AV model 
[156]. Lastly, the use of the ALE method required to maintain a single fluid domain 
throughout the cardiac cycle. This was achieved by using a very low contact offset in the 
structural domain, which prevented the leaflets from completely closing and splitting the 
fluid domain during leaflet coaptation. In doing so, a small orifice was still present even 
after closure, which led to a very low amount of valvular regurgitation. The prediction of 
the velocity along the y-axis at a point and the volume flow rate at a plane, both upstream 
of the leaflets, yielded 0.018 m/s and 4.510-7 m3/s, respectively (i.e., 44% and 59% 
decrease, respectively, vs. the previous model), suggesting the near absence of 
regurgitation in the model. This low regurgitation could be completely avoided by adopting 
computational methodologies such as overset meshing or traditional fixed-grid methods.
64 
CHAPTER 4: 
 SPECIFIC AIM 2: To quantify AV hemodynamics and leaflet dynamics under 
hypertensive conditions  
The main objective of this aim was to quantify the alterations in AV hemodynamics, 
regional leaflet WSS characteristics and leaflet dynamics under prehypertensive 
(PreHTN) and stage-1 hypertensive (HPN) conditions. The same computational 
strategy as that designed in Aim 1 was implemented and adapted to simulate AV flow 
under hypertension. Boundary conditions representing PreHTN and HPN conditions 
were determined and prescribed in the model. AV hemodynamics was analyzed in terms 
of velocity and vorticity fields. WSS characteristics (TSM, OSI) were computed locally 
on the leaflet surface, and leaflet dynamics was investigated by capturing the leaflet 
deformation profile, coaptation angle and stretch ratios. 
4.1.  Methods 
The same geometry, spatial discretization, material models and FSI modeling 
strategy as in Aim 1 were considered in this aim. However, the PreHTN and HPN 
models implemented different boundary conditions at the outlet of the valve. 
4.1.1. Boundary Conditions 
4.1.1.1.  AV Inlet and Coronary Outlet Conditions 
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The same velocity profile as in the normotensive model was prescribed at the 
valvular inlet of the PreHTN and HPN models in order to maintain the same physiologic 
cardiac output. Although the increase in aortic pressure associated with HPN is expected 
to increase diastolic coronary flow and myocardial perfusion, the coronary autoregulation 
mechanism compensates for this effect by triggering the remodeling of the coronary 
arteries and increasing coronary flow resistance. The flow simulations under PreHTN and 
HPN conditions accounted for this mechanism and assumed the maintenance of 
physiologic coronary flow levels by imposing the same transient coronary outlet velocity 
as in the normotensive model. The external mechanical pressure imposed on the leaflets 
was also similar to that implemented in the normotensive model.  
4.1.1.2.  Aortic Outlet Pressure Conditions 
 
While the normotensive model operated with a zero-gauge pressure at the aortic outlet, 
non-zero pressure conditions had to be determined to replicate the increase in aortic 
pressure under PreHTN (125/80 mmHg) and HPN (130/90 mmHg). In a simple one-
dimensional representation, the flow rate (Q) and the pressure gradient across the valve 
(P) are related by the valvular flow resistance (R) as: 





      (24) 
A physiologic AV flow resistance enables the maintenance of a physiologic CO of 
5 L/min under normal aortic pressure conditions (120/80 mmHg). However, given the 
strong dependence of R  on the leaflet material, and the approximation made by the 
isotropic, homogeneous Mooney-Rivlin model, the effective resistance in the 
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normotensive model was expected to differ from the native AV resistance. As a result, the 
production of a physiologic CO in the normotensive model was expected to be achieved 
under a non-physiologic pressure gradient across the valve. Therefore, the determination 
of appropriate outlet pressure conditions ( aorticP ) reflecting an actual increase in aortic 
pressure ( aorticP ) of +5 and +10 mmHg under PreHTN and HPN, respectively, required: 1) 
the assessment of the actual time-averaged pressure gradient across the normotensive 
model ( modelP ), and 2) its comparison to the physiologic time-averaged pressure gradient 
across the native AV ( 44physioP    mmHg) via the calculation of a pressure scaling factor 
( physio modelP P    ), and 3) the determination of the scaled gauge pressure to be 
prescribed at the aortic outlet ( aortic aorticP P  ). 
 The mean transvalvular pressure gradient predicted across the normotensive AV 
model over one cardiac cycle was 10.65modelP    mmHg, which resulted in a pressure 
scaling factor 4.13  . The resulting scaled increase in aortic pressure to model PreHTN 
and HPN was calculated as 1.21aorticP   mmHg (161.4 Pa) and 2.42aorticP  mmHg (322.8 
Pa), respectively. Since the increase in aortic pressure under PreHTN is only effective 
during the systolic phase, this boundary condition was only enforced during systole and 
then switched to zero gage pressure for the rest of the cardiac cycle (Figure 30a). In 
contrast, for HPN, which imposes a sustained elevated aortic pressure throughout the cycle, 





4.2.1. Flow Characteristics 
The vorticity contour and velocity vector fields in the LCL, RCL and NCL plane 
under PreHTN (Figure 31) and HPN (Figure 32) were assessed and compared qualitatively. 
Until peak systole, both models exhibited essentially similar vortex dynamics, suggesting 
the weak dependence of AV hemodynamics on systolic aortic hypertension. During the 
deceleration phase, intense vortices associated with strong flow rotationality were observed 
near the tip and belly regions of the leaflets in both the PreHTN and HPN condition. At the 
onset of diastole, the PreHTN condition exhibited weak vortices in the aortic sinus, while 
the HPN condition predicted moderate vortices near the belly and base regions of the 
leaflets. The vortices in the sinus and near the leaflets slowly dissipated into the coronary 
arteries and the aorta during the rest of the diastolic phase. This observation is supported 
by the calculation of the plane-averaged vorticity, which revealed a 9.1-fold increase in the 
LCL plane relative to the NCL plane, and an 8.5-fold increase in the NCL plane relative to 
the RCL plane under PreHTN (Figure 33). HPN condition predicted a 9.3-fold increase in 
the LCL plane relative to the NCL plane, and a 9.3-fold increase in the NCL plane relative 
Figure 30: Aortic pressure during the cardiac cycle in the prehypertensive (a) and 
hypertensive case (b) 
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to the RCL plane. HPN condition contributed to 28.7%, 15.3% and 27.2% increase in 
plane-averaged vorticity in the LCL, RCL and NCL, respectively, vs. the PreHTN 
condition. 
Figure 31: Vorticity and velocity field in the leaflet bisecting planes during the 
acceleration phase (t=80 ms), at peak systole (t=130 ms), during deceleration phase 





Figure 32: Vorticity and velocity field in the leaflet bisecting planes during the 
acceleration phase (t=80 ms), at peak systole (t=130 ms), during deceleration phase 
(t=230 ms) and during diastole (t=400 ms and t=560 ms) under hypertension 
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4.2.2. WSS Characteristics 
 
The WSS distributions on the fibrosa of the LCL, RCL and NCL were captured at 
different phases of the cardiac cycle in the PreHTN (Figure 34) and HPN condition (Figure 
35). During the acceleration phase, alterations in WSS spatial distribution were observed 
on either side of the axis of symmetry on the leaflets and also along the NCL axis under 
the PreHTN and HPN condition (1). At peak systole, both models predicted increased WSS 
levels in the tip and the belly of the LCL and RCL. The NCL contour exhibited regions of 
increased WSS levels in the tip region only (2). During the deceleration phase, the LCL 
and RCL exhibited comparatively similar WSS distributions characterized by several 
pockets of elevated WSS along the free-edge and the belly region (3) under both PreHTN 
and HPN condition. In the NCL, these pockets were larger in size and were characterized 
by higher WSS magnitude in the PreHTN condition only. Diastole was marked by a 
reduction in WSS on the leaflets in the HPN condition, with the RCL displaying the highest 
WSS levels in the tip and belly region relative to other leaflets. The rest of the diastolic 
phase was characterized by the attenuation of WSS levels. HPN condition displayed 
Figure 33: Average vorticity measured in the LCL, RCL and NCL plane 




increase in WSS level in the tip of the LCL and reduction in WSS level in the tip and belly 
regions of RCL and NCL, relative to the PreHTN condition.  
Figure 34: WSS distribution in the fibrosa of the LCL, RCL and NCL 
under prehypertensive condition during different phases of the cardiac 
cycle 
Figure 35: WSS distribution in the fibrosa of the LCL, RCL and NCL 
under hypertensive condition during different phases of the cardiac cycle 
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The temporal WSS variations over the cardiac cycle were extracted along the radial 
(Figure 36) and circumferential directions (Figure 37). Similar to the normotensive model, 
these waveforms revealed the typical low-oscillatory nature of the WSS environment on 
the leaflet fibrosa, and high radial WSS levels in the tip region. The radial WSS waveforms 
revealed essentially similar WSS oscillations and frequency in both the preHTN and HPN 
models. The belly region of the NCL exhibited reversal in WSS directionality during 
systole under the HPN condition, which was not a feature predicted by the PreHTN model. 
The circumferential WSS waveforms displayed reversal in WSS directionality in the 
HPN condition but not in the PreHTN condition. The waveforms captured under HPN 
condition also revealed smaller WSS oscillations on the LCL and RCL than under PreHTN 
Figure 36: Temporal variations of the radial WSS in the tip, belly and base of the LCL, 
RCL and NCL under normotensive pressure, prehypertension and stage-1 hypertension 
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condition. The tip region of the NCL showed increased oscillations under HPN condition, 
compared to the PreHTN condition. 
These qualitative observations were supported by the analysis of the regional TSM 
and OSI predictions for both WSS components (Table 11 and Table 12, respectively). The 
HPN condition reported higher radial WSS magnitude (0.09<TSM<1.93 Pa) across the 
fibrosa compared to the PreHTN condition (0.07<TSM<1.93 Pa). The most significant 
difference between PreHTN and HPN radial TSM was measured at the base region of the 
leaflets (37%, 23% and 57% increase on the LCL, RCL and NCL, respectively in the HPN 
condition vs. the PreHTN condition). The circumferential TSM was one-order-of-
magnitude lower than the radial TSM, consistent with the normotensive  condition. The 
HPN condition reported higher circumferential WSS magnitude (0.04<TSM<0.11Pa) 
Figure 37: Temporal variations of the circumferential WSS in the tip, belly and base 
region of the LCL, RCL and NCL in the radial direction under normotensive pressure, 
prehypertension and stage-1 hypertension 
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across the fibrosa compared to the PreHTN condition (0.05<TSM<0.1 Pa). HPN condition 
also yielded a 44% and 32% increase in TSM in the tip region of LCL and NCL, 
respectively, relative to the PreHTN condition .  
WSS directionality in the radial direction was found to be mostly unidirectional in the 
tip region of the leaflets and bidirectional in the base region for both the PreHTN and HPN 
condition. The belly region of the LCL and RCL also experienced bidirectional WSS under 
PreHTN condition. Similarly, the RCL belly also exhibited bidirectional WSS under HPN 
condition. HPN condition contributed to a 0.17-point increase in OSI in the base region of 
LCL and NCL, relative to the PreHTN condition. Circumferential OSI data revealed mostly 
bidirectional WSS in the tip region of the leaflets under PreHTN condition and 
unidirectional WSS in the tip of the leaflets under HPN condition. The belly and base 
region were exposed to mostly unidirectional WSS. HPN condition predicted 0.34- and 
0.42- point decrease in OSI in the LCL tip and base region, respectively, relative to the 
PreHTN condition. 
Table 11: Radial TSM and OSI data in the tip, belly and base of the leaflets under 
prehypertension and hypertension 
Prehypertension Hypertension
Leaflet TSM (Pa) OSI TSM (Pa) OSI
tip  belly base tip  belly base tip  belly base tip  belly base
LCL 1.87 0.21 0.07 0.10 0.23 0.31 1.87 0.24 0.10 0.15 0.18 0.47
RCL 1.93 0.21 0.07 0.13 0.35 0.45 1.93 0.23 0.09 0.15 0.28 0.45
NCL 1.84 0.21 0.07 0.08 0.11 0.31 1.82 0.22 0.12 0.14 0.19 0.48
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Table 12: Circumferential TSM and OSI data in the tip, belly and base of the leaflets 
under prehypertension and hypertension 
Prehypertension Hypertension
Leaflet TSM (Pa) OSI TSM (Pa) OSI
tip belly base tip  belly base tip  belly base tip  belly base
LCL 0.08 0.05 0.05 0.46 0.07 0.50 0.11 0.05 0.04 0.12 0.08 0.08
RCL 0.10 0.08 0.05 0.26 0.10 0.19 0.10 0.04 0.04 0.34 0.29 0.15
NCL 0.08 0.08 0.05 0.20 0.32 0.19 0.11 0.06 0.06 0.17 0.16 0.27
4.2.3. Leaflet Dynamics 
Leaflet profile was investigated visually at different phases of the cardiac cycle in the 
PreHTN and HPN models (Figure 38). The leaflet profiles were similar during systole for 
Figure 38: Leaflet deformation profile at peak systole (green), during deceleration 
phase (red) and during diastole (blue) under prehypertension and hypertension 
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both pressure conditions. During diastole, the HPN condition for all leaflets showed 
increase in leaflet coaptation profile, characterized by the increased leaflet curvature, 
compared to the PreHTN condition.  
The leaflet coaptation angle for the PreHTN and HPN condition were quantified 
(Table 13). HPN condition predicted a substantial decrease in coaptation angle in the 
leaflets (25%, 25% and 26% decrease in the LCL, RCL and NCL, respectively, relative to 
the PreHTN condition). 
Table 13: Leaflet coaptation angle under prehypertension and hypertension 
Leaflet 
type 





Prehypertension 25.87 25.33 25.20 
Stage-1 hypertension 19.36 19.02 18.88 
 
Leaflet mechanics was also assessed by evaluating the regional leaflet stretch ratios 
in the radial and circumferential direction under PreHTN (Table 14) and HPN conditions 
(Table 15). PreHTN and HPN condition predicted up to 8% increase in radial and 
circumferential stretch ratio in the tip and belly of the RCL, relative to the base region. 
LCL and NCL regional stretch ratios were found to be homogenous throughout the fibrosa 
under PreHTN and HPN conditions. HPN condition contributed to up to 3% and 2% 
increase in radial and circumferential stretch, respectively, in both the base and belly region 
of NCL, relative to the PreHTN condition. 
The systolic-average and diastolic-average stretch characteristics on the leaflets 
were computed under PreHTN (Figure 39) and HPN conditions (Figure 40). PreHTN 
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condition contributed to an overall increase in diastolic radial stretch by 33%, 28% and 
39% in the LCL, RCL and NCL, respectively, vs. the systolic stretch ratio. Similarly, 
circumferential stretch ratio during diastole was increased by 26%, 20% and 29% in the 
LCL, RCL and NCL, respectively, vs. the systolic stretch ratio under PreHTN condition. 
HPN condition resulted in increased diastolic radial stretch (39%, 30% and 45% increase 
in the LCL, RCL and NCL, respectively) and increased diastolic circumferential stretch 
(29%, 23% and 31% increase in the LCL, RCL and NCL, respectively) vs. the systolic 
stretch ratio. 
Table 14: Regional stretch characteristics under prehypertension 





LCL 1.03 1.03 1.03 1.03 
RCL 1.09 1.10 1.01 1.07 




LCL 1.01 1.01 1.01 1.01 
RCL 1.08 1.07 1.00 1.05 
NCL 1.02 1.02 1.01 1.02 
 
Table 15: Regional stretch characteristics under hypertension 




LCL 1.04 1.04 1.03 1.04 
RCL 1.09 1.11 1.04 1.08 




LCL 1.01 1.01 1.01 1.01 
RCL 1.08 1.08 1.02 1.06 









Figure 39: Regional stretch characteristics on AV leaflets during systole and 
diastole under prehypertension 
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Figure 40: Regional stretch characteristics on AV leaflets during systole and 
diastole under hypertension 
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4.3.  Discussion 
The main objective of this second aim was to characterize the hemodynamic changes 
experienced by the AV under PreHTN and HPN conditions. The approach consisted of 
substituting the aortic outlet boundary conditions with the PreHTN and HPN aortic 
pressure and running FSI simulations to predict the effect on flow and the leaflet dynamics 
under HPN conditions. This was achieved by comparing the results of the HPN models 
relative to the normotensive model as discussed below: 
4.3.1. Effects of Hypertension on AV Hemodynamics 
HPN condition predicted increase in vorticity magnitude near the tip region during 
systole and in the vicinity of the belly and base region of the leaflets during diastole, 
relative to the normotensive condition. Plane-average vorticity was increased in a pressure-
dependent manner in the leaflets with HPN contributing to 36%, 31% and 34% increase in 
flow vorticity in the LCL, RCL and NCL, respectively, relative to the normotensive 
condition. 
These alterations in flow rotationality under PreHTN and HPN conditions led to 
subsequent alterations in WSS magnitude and directionality in the leaflets. WSS overloads 
were detected on the leaflets (up to 24%, 22% and 13% increase in leaflet-average TSM in 
the LCL, RCL and NCL, respectively, under PreHTN condition and up to 40%,  33% and 
27% increase in leaflet-average TSM in the LCL, RCL and NCL, respectively, under HPN 
condition, relative to the normotensive condition). This variation in WSS environment 
between the coronary and non-coronary leaflets could be associated with the impact of 
coronary flow on the leaflet mechanics. Unlike the PreHTN condition, HPN condition also 
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predicted an increase in TSM in the base region of the leaflets (37%, 22% and 10% increase 
in TSM in the LCL, RCL and NCL, respectively, vs the normotensive condition).  
WSS bidirectionality characteristics were also affected in the PreHTN and HPN 
conditions. OSI predictions revealed site-specific alterations on the leaflets, marked by a 
pressure-dependent increase in WSS oscillation on the base and a pressure-dependent 
increase in WSS pulsatility in the tip region of the leaflets. PreHTN and HPN condition 
predicted 0.27- and 0.2-point decrease in OSI in the NCL belly, respectively, relative to 
the normotensive condition. HPN condition also predicted a 0.23- and 0.19-point increase 
in OSI in the base of LCL and NCL, respectively, relative to the normotensive condition.  
Overall, HPN condition contributed to alterations in vorticity dynamics, increased WSS 
magnitude and alterations in WSS bidirectionality on the AV leaflets. The increased 
bidirectionality and low WSS magnitude on the leaflets especially, the NCL might explain 
its high susceptibility to calcification [157]. HPN condition also predicted increased TSM 
and OSI in the base region of the leaflets, which have been demonstrated to be the primary 
site of calcification [158], [159]. 
4.3.2. Effects of Hypertension on Leaflet Dynamics 
HPN condition predicted increase in leaflet coaptation profile (29%, 30% and 30% 
decrease in coaptation angle in the LCL, RCL and NCL, respectively, vs. the normotensive 
condition). Leaflet radial stretch also increased in a pressure-dependent manner (LCL: 2% 
and 3% increase and NCL: 3% and 6% increase, respectively, under PreHTN and HPN 
condition, vs. the normotensive condition). Similarly, HPN condition estimated up to 2% 
increase in the circumferential stretch in the NCL, vs. the normotensive condition. The 
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diastolic vs. systolic stretch characteristics was increased by 5% radially and 3% 
circumferentially in the leaflets under HPN condition, vs. the normotensive condition.  
The present study suggested the increase in leaflet deformation under HPN condition. 
Overall, PreHTN and HPN condition predicted pressure-dependent increase in radial 
stretch characteristics. This increased stretch was predominantly seen in the NCL, 
suggesting the high impact of coronary flow on leaflet deformation. Circumferential stretch 
was also increased in the leaflets but was lower as expected. The low increase in 
circumferential stretch in the leaflets can be explained by the additional stiffness of the 
leaflets in circumferential direction [118]. Overall, these results strongly highlight the 
effect of increased aortic pressure on AV leaflet dynamics. 
4.3.3. Potential Implications for CAVD Pathogenesis 
The present study suggests the presence of valvular flow abnormalities and abnormal 
hemodynamic stress environment on the AV leaflets. The results from this specific aim 
validate the initial hypothesis. HPN conditions predicted WSS overloads and alterations in 
WSS bidirectionality on the AV leaflets in a pressure-dependent manner. A previous 
mechanobiological study has demonstrated the promotion of inflammation and remodeling 
(hallmarks of CAVD) on the leaflet tissue, when exposed to increased WSS magnitude and 
alterations in WSS bidirectionality [64]. That study revealed that increased WSS 
magnitude promoted the upregulation of BMP-4 and TGF-β1, a characteristic of 
inflammation. Results also showed that remodeling was characterized by the upregulation 
of MMP-2 and MMP-9 under combined alterations of WSS magnitude and bidirectionality. 
The present study also suggested an increase in leaflet stretch characteristics in both 
directions under HPN condition. Increased cyclic stretch has been shown to promote 
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remodeling by the upregulation of proteolytic enzymes such as MMP-1, MMP-2 and 
MMP-9 [160]. Another in-vitro study has also reported evidence of valvular calcification 
under altered stretch in a BMP-dependent manner [161].  
Therefore, based on the findings of this study and demonstrated sensitivity of AV 
leaflets to abnormal WSS environment and stretch alterations, this study suggests the 
existence of a mechanobiological etiology for CAVD in HPN patients. However, further 
validation using in-vitro techniques is needed to conclude the findings of this aim and to 
ascertain the potential hemodynamic role of HPN in CAVD development. Once that’s 
demonstrated, different clinical strategies of diagnosis and treatment could be designed to 
isolate the vulnerable population, slow the progression of HPN using antihypertensive 
medications, address any flow abnormalities early on or block the pathological cascades at 
the later stages.  
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CHAPTER 5: 
 SPECIFIC AIM 3: To investigate the effects of hypertension on coronary resistance and 
LV workload 
The main objective of this aim was to investigate the long-term effects of hypertension on 
coronary flow resistance and LV workload. Myocardial perfusion is maintained across a 
wide range of aortic pressure via an autoregulation mechanism. Coronary flow resistance 
is therefore expected to increase under elevated aortic pressure in order to maintain 
physiologic coronary flow levels. However, the extent to which coronary resistance 
changes under PreHTN and HTN is unknown. Similarly, HTN has been associated with 
increases in ventricular mass and workload but this association has not yet been 
quantified. For this purpose, the models from Aim 1 and Aim 2 were revisited, and 
coronary flow resistance and LV work were computed and compared for the different 
pressure conditions. 
5.1.  Methods 
5.1.1. Coronary Flow Resistance Calculation 
Coronary flow resistance was computed in the LCA and RCA for all pressure 
conditions to characterize the effects of hypertension on coronary perfusion and arterial 
remodeling. The transient LCA and RCA outlet pressures were extracted from the 
normotensive, PreHTN and HPN models. The instantaneous coronary perfusion pressure 
( P ) in each coronary artery was then evaluated as the difference between the aortic 
outlet pressure and 
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the coronary outlet pressure at each time step. The instantaneous coronary flow resistance 
(R) was then calculated as  





  ,    (25) 
where Q  is the instantaneous coronary volume flow rate. This resistance was then averaged 
over the systolic and diastolic phases to obtain the average coronary flow resistance for 
systole and diastole. Coronary flow resistance is expected to be higher during systole than 
diastole due to the myocardial contraction. 
 Additionally, the benefits of the coronary remodeling process were quantified by 
running new simulations aimed at predicting the flow through the valve under stage-1 
hypertension in the absence of coronary remodeling. This was achieved practically by 
running the HPN model from Aim 2 using the same coronary flow resistance (i.e., same 
coronary outlet pressures) as that computed in the normotensive model. All other 
conditions remained the same in this non-remodeling hypertensive (nHPN) model. 
Flow results were assessed in terms of the vorticity-velocity fields captured in the 
vertical planes bisecting the coronary leaflets, and coronary flow rates were quantified at 
the coronary outlets of the nHPN model. Coronary flow metrics such as the peak diastolic 
velocity, diastolic-systolic velocity ratio, (i.e., ratio of average diastolic to systolic coronary 
flow velocity [162]), and the baseline coronary flow rate (i.e., product of the peak velocity 
and the cross-sectional area of the arterial lumen [163]) were also calculated. These results 
were then compared with those predicted by the HPN model from Aim 2. 
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5.1.2. Stroke Work Calculation 
The LV workload or stroke work (W) is defined as the work done by the LV to pump 
the stroke volume (SV) during a cardiac cycle. From a thermodynamic perspective, the 
exact value of the stroke work can be obtained by calculating the area of the region enclosed 




W PdV  ,     (26) 
where P represents the instantaneous ventricular pressure and V  represents the 
instantaneous LV volume. Therefore, the LV workload for each pressure condition was 
calculated by first plotting the P-V curve and then approximating the enclosed area using 
a trapezoidal numerical integration method. The transient LV pressure for each case was 
directly extracted from the computed valvular inlet pressure, while the temporal variations 
in LV volume (which were not modeled) were obtained from the literature [133]. 
5.2.  Results 
5.2.1. Coronary Flow Resistance 
Average coronary flow resistances during systole and diastole were calculated for the 
LCA (Figure 41) and the RCA (Figure 42) under normotensive, PreHTN and HPN 
conditions. Both systolic and diastolic coronary flow resistances were found to increase in 
a pressure-dependent manner. Under PreHTN condition, the systolic and diastolic LCA 
resistance increased by 79% and 10%, respectively, relative to the normotensive condition. 
Under HTN condition, this increase rose by 168% and 140%, respectively. Similarly, the 
systolic and diastolic RCA resistance increased by 20% and 27%, respectively, under 
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PreHTN condition relative to the normotensive condition. Under HPN condition, this 
increase was 45% and 409%, respectively.  
 
Figure 41: Coronary flow resistance in the LCA during systole and diastole 
under normotensive, prehypertensive and hypertensive condition 
Figure 42: Coronary flow resistance in the RCA during systole and diastole 
under normotensive, prehypertensive and hypertensive condition 
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In the absence of coronary remodeling, the nHPN condition revealed a substantial 
derangement in flow structure (Figure 43), characterized by increase in vorticity magnitude 
due to the diastolic increase in coronary flow (up to 13- and 47-fold increase in LCA and 
RCA flow rate, respectively) relative to HPN condition (Figure 44).  The nHPN condition 
predicted increases in peak diastolic velocity, diastolic-systolic velocity ratio, and baseline 
coronary flow rate in the LCA (3.8-, 1.2- and 3.9-fold increase, respectively) and RCA 
(14.6-, 1.6- and 13-fold increase, respectively), relative to the HPN condition. 
 
Figure 43: Vorticity-velocity field in the LCL and RCL plane during diastole in 
the HPN and nHPN condition 
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5.2.2. LV Workload 
The LV P-V diagrams were plotted for the normotensive, PreHTN and HPN 
conditions (Figure 45). The PV curve under all three pressure conditions were 
characterized by the typical ventricular filling (marked by pressure decrease at the start and 
slow increase with increase in volume), isovolumetric contraction, ejection (marked by 
volume decrease with pressure increase to peak value followed by pressure attenuation) 
and isovolumetric relaxation phase. The most substantial alterations to the normotensive 
P-V response were exhibited by the HPN model during the contraction, relaxation and 
ejection phase. The stroke work increased by 21% in the PreHTN condition, and by 50% 
in the HPN condition, relative to the normotensive condition (Figure 46). 






Figure 45: LV P-V chart under normotensive, prehypertensive and 
hypertensive condition 
Figure 46: Stroke work calculated under normotensive, prehypertensive 
and hypertensive condition 
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5.3.  Discussion 
5.3.1. Effect of Hypertension on Coronary Flow Resistance 
Coronary remodeling is essential to the maintenance of myocardial perfusion. During 
the remodeling process, the increase or decrease in resistance ensures constant flow 
through the coronary arteries. Coronary autoregulation ensures the maintenance of constant 
flow despite changes in aortic pressure such as those caused by HPN. Hence, coronary flow 
resistance was expected to increase under hypertension to compensate for the increased 
aortic pressure and to account for arterial remodeling and coronary autoregulation. As 
compared to the normotensive condition, HPN condition resulted in increased coronary 
flow resistance (LCA: 168% and 140% increase and RCA: 45% and 409% increase, 
respectively, during systole and diastole). This increase in coronary flow resistance is a 
characteristic of the remodeling and autoregulation process discussed above. Thus, this 
study highlighted the process of physiologic coronary remodeling under HPN conditions 
via increase in flow resistances.  
The significance of coronary remodeling was also demonstrated in the results of the 
nHPN condition. Results predicted substantial increases in coronary flow rates and flow 
parameters. Increase of these coronary flow parameters have commonly been associated 
with coronary artery disease [164]–[166]. However, it is well known that autoregulation 
maintains constant coronary perfusion under elevated pressure, as shown by the increased 
flow resistance in this aim. Therefore, the changes seen under the nHPN condition are not 
physiologic and cannot be associated with any coronary artery complications. These results 
only highlight the importance of autoregulation and coronary remodeling, whose absence 
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would otherwise lead to drastic effects on the coronary flow as shown by the nHPN 
condition.  
Overall, this study quantified the effects of HPN on the coronary flow by 
characterizing the increase in flow resistance, which is crucial to the maintenance of 
myocardial perfusion. 
5.3.2. Effect of Hypertension on LV Functionality 
LV workload was assessed using P-V chart and stroke work evaluations. The P-V 
chart obtained in the normotensive model was compared with the ones reported in 
ventricular studies and was shown to represent relatively similar pressure and volume at 
the start and the end of the filling phase [167], with a maximum difference below 20 % for 
both quantities. The stroke volume was measured at 77.8 mL, consistent with physiologic 
and published values (70-80 mL) [144], [167], and the stroke work was calculated at 1.18 
J, close to the value reported (1.08 J) [168]. 
 Ventricular overloads were measured in the PreHTN and HPN conditions (21% and 
50% increase, respectively, relative to the normotensive condition). This increase in 
ventricular workload is normally associated with increase in muscular mass and thickness 
of the LV wall, leading to LV hypertrophy [169]. Therefore, this present study suggests a 
strong association between HPN and LV hypertrophy. However, further analysis is 







In this thesis, a 3D coronary-AV model was designed, and fluid-structure simulations were 
performed using an ALE-FSI modeling strategy. The thesis studied the effects of 
hypertension on the hemodynamic stress environment of AV leaflets, coronary flow 
resistance and LV functionality. Three research questions were formulated at the start of 
this study (see chapter 2) and were addressed by the results from Aims 1 – 3.   
Does hypertension affect the hemodynamic stress environment on the AV leaflets, And to 
what extent? 
This study demonstrated the existence of altered hemodynamic stress environment on 
the AV leaflets via increased spatial and temporal variation in WSS characteristics in a 
pressure-dependent manner, both regionally and globally. HPN led to increased WSS 
magnitude on the leaflets exhibited by the 40%, 33% and 27% increase in TSM in the LCL, 
RCL and NCL, respectively, relative to the normotensive condition. HPN condition also 
predicted increased WSS bidirectionality in the leaflet base, shown by the 0.23-and 0.19-
point increase in OSI in the LCL and NCL, respectively, relative to the normotensive 
condition. Increased WSS magnitude and altered WSS bidirectionality were recorded 
across the fibrosa, regardless of the leaflet type, thereby, suggesting the presence of 
abnormal WSS environment on the AV leaflets under HPN condition.
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What is the impact of hypertension on coronary flow and the maintenance of myocardial 
perfusion? 
In specific aim 3, coronary flow resistance was characterized under normotensive and 
HPN conditions. The HPN condition contributed up to 168% and 400% increase in 
resistance in the LCA and RCA, respectively, relative to the normotensive condition. This 
increase in flow resistance is essential in maintaining the myocardial perfusion despite the 
increase in aortic pressure. The study also discussed the effects of HPN on coronary flow 
prior to remodeling. Hypertension in the absence of coronary arterial remodeling resulted 
in substantial and adverse effects on coronary flow, shown by the 13- and 47-fold increase 
in the LCA and RCA flow rate, respectively, vs the HPN condition with remodeling. 
Therefore, this study demonstrated the effect of HPN on coronary flow resistance and 
discussed the important role played by remodeling in the coronary circulation under 
hypertension.  
What impact does hypertension have on left ventricular function? 
This study evidenced the substantial impact of HPN on LV function by characterizing 
the ventricular workload. In specific aim 3, stroke work, calculated from the P-V chart, 
was assessed and compared under normotensive, PreHTN and HPN conditions. The results 
revealed ventricular overloads in the PreHTN and HPN conditions, characterized by the 
21% and 50% increase in stroke work, respectively, relative to the normotensive condition. 
These findings suggest a strong association between HPN and LV hypertrophy.  
In conclusion, this thesis demonstrated that HPN contributes to alterations in coronary 
flow resistance, ventricular overload and WSS abnormalities on the AV leaflets. These 
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WSS abnormalities might lead to CAVD pathogenesis, which requires further analysis and 
validation. However, results from this study provide important insights on the association 
between HPN and CAVD and compelling support to the hemodynamic etiology linking 




























3D FSI valve models were developed and were able to simulate blood flow under 
normotensive, PreHTN and HPN conditions. These models predicted the existence of 
abnormal hemodynamics, alterations in WSS environment and increased leaflet 
deformation, increased coronary resistance and ventricular overloads in the PreHTN and 
HPN case. However, this goal was achieved by making simplifications to the model and 
the methodology. These limitations have already been extensively discussed in specific 
aim 1. The present chapter revisits those limitations in a summarized manner as follows: 
 the valvular geometry consisted of identical, equiangularly spaced leaflets and 
sinus unlike the realistic aortic root  
 Secondly, the leaflet material was approximated as isotropic and homogenous 
instead of accounting for the anisotropy in the leaflets due to the fiber orientation  
 Blood flow was modeled as laminar although the flow is transitional at peak systole
 The adopted ALE method generated a gap between the leaflets leading to 
regurgitation during diastole 
In conclusion, the models had certain limitations which were thoroughly discussed and 
could be vastly improved in future studies by adopting new methods and modeling 
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